Litigation

Recent Posts

High Court Upholds 3rd Circuit's Ruling, Finds Stockholder's Suit Against Merck Was Timely
Posted on 27 Apr 2010 by Michael Lefkowitz

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on April 27 affirmed a Third Circuit U.S. Court of Appeals ruling that a shareholder derivative lawsuit over Merck & Co. Inc.'s marketing of Vioxx was timely and held that the statute of... Read More

J&J, FDA Leaders Take Heat For Phantom Recall'
Posted on 30 Sep 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) Johnson & Johnson executives and the Food and Drug Administration both shouldered the blame Thursday for a secret recall in which hired contractors quietly bought up defective painkillers to clear them from store shelves. J&J... Read More

Australian Court: Vioxx Doubled Heart Attack Risk
Posted on 8 Mar 2010 by LexisNexis Litigation Resource Community Staff

SYDNEY, Australia – (AP) The once-popular painkiller Vioxx doubled the risk of heart attack and was unfit for consumption, an Australian court ruled Friday, awarding a man leading a class action suit against the drug's maker 287,000 Australian... Read More

Supreme Court Says Vioxx Lawsuit Can Proceed
Posted on 27 Apr 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. – (AP) The Supreme Court said Tuesday investors who lost millions betting on the blockbuster drug Vioxx can sue Merck & Co. over whether the pharmaceutical giant provided enough information about the painkiller's risks before... Read More